Nanobiotix S.A. (NASDAQ:NBTX – Get Free Report)’s stock price was down 1% during mid-day trading on Friday . The stock traded as low as $2.82 and last traded at $2.83. Approximately 44,226 shares were traded during mid-day trading, an increase of 18% from the average daily volume of 37,454 shares. The stock had previously closed at $2.86.
Nanobiotix Trading Down 1.0 %
The stock has a fifty day moving average of $3.38 and a 200 day moving average of $4.52.
About Nanobiotix
Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.
Featured Articles
- Five stocks we like better than Nanobiotix
- 3 Monster Growth Stocks to Buy Now
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- What is the NASDAQ Stock Exchange?
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- What is the Shanghai Stock Exchange Composite Index?
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Nanobiotix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanobiotix and related companies with MarketBeat.com's FREE daily email newsletter.
